tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Marc Frahm, 18 are a BUY (66.67%), 9 are a HOLD (33.33%).
Analyst Marc Frahm, currently employed at TD COWEN, carries an average stock price target met ratio of 72.5% that have a potential upside of 12.88% achieved within 151 days.
Marc Frahm’s has documented 54 price targets and ratings displayed on 14 stocks. The coverage is on Healthcare, Pharmaceuticals sectors.
Most recent stock forecast was given on INCY, yte at 27-Apr-2026.
Analyst best performing recommendations are on TBPH (THERAVANCE BIOPHARMA).
The best stock recommendation documented was for INCY (YTE) at 10/29/2025. The price target of $101 was fulfilled within 5 days with a profit of $10.82 (12%) receiving and performance score of 24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Sep-2026
28 days ago
(24-Sep-2026)
0/9 (0%)
$6.67 (46.55%)
Buy Since 29-Oct-2019
$17
$-0.03 (-0.18%)
$15
3 months 15 days ago
(07-Jul-2026)
13/15 (86.67%)
$-0.01 (-0.06%)
479
Buy Since 17-Jun-2025
$26
3 months 23 days ago
(29-Jun-2026)
0/2 (0%)
$12.85 (97.72%)
Hold Since 07-Apr-2026
$17
$-0.63 (-3.57%)
$14
6 months 15 days ago
(07-Apr-2026)
2/3 (66.67%)
$0.44 (2.66%)
8
Hold Since 15-Sep-2021
$15
$-2.63 (-14.92%)
$13
6 months 29 days ago
(23-Mar-2026)
9/10 (90%)
$0.25 (1.69%)
232
Which stock is Marc Frahm most bullish on?
What Year was the first public recommendation made by Marc Frahm?
